Repligen Corp. (RGEN)
161.73
-2.07
(-1.26%)
USD |
NASDAQ |
Dec 11, 16:00
161.73
0.00 (0.00%)
After-Hours: 20:00
Repligen Free Cash Flow: 103.47M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Enovis Corp. | 22.76M |
| Teleflex, Inc. | 264.33M |
| Globus Medical, Inc. | 569.94M |
| Perspective Therapeutics, Inc. | -106.85M |
| Xtant Medical Holdings, Inc. | 5.123M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 48.10M |
| Cash from Investing (Quarterly) | -7.783M |
| Cash from Financing (Quarterly) | -0.239M |
| Free Cash Flow Per Share (Quarterly) | 0.7556 |
| Free Cash Flow to Equity (Quarterly) | 39.91M |
| Free Cash Flow to Firm (Quarterly) | 47.79M |
| Free Cash Flow Yield | 1.13% |